Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Feb-21 7:49 PM View:  | Salesforce.com (CRM) | 22-Feb-21 | Option Exercise | 411 | -- | -- | < 1% 86.91K to 87.32K | |
| 23-Nov-20 7:05 PM View: | Salesforce.com (CRM) | 22-Nov-20 | Option Exercise | 514 | -- | -- | < 1% 86.39K to 86.91K | |
| 21-Sep-20 4:01 PM View: | Pain Therapeutics Inc. (SAVA) | 18-Sep-20 | Market Purchase | 36,281 | $8.92 | $323,627.00 | 4% 876.34K to 912.62K | (16%) |
| 17-Sep-20 5:15 PM View: | Pain Therapeutics Inc. (SAVA) | 17-Sep-20 | Market Purchase | 213,719 | $6.98 | $1,491,760.00 | 32% 662.62K to 876.34K | 7% |
| 01-Sep-20 8:44 PM View: | Salesforce.com (CRM) | 31-Aug-20 | Market Sale | 15,000 | $271.87 | $4,078,070.00 | (15%) 101.39K to 86.39K | 16% |
| 24-Aug-20 7:17 PM View: | Salesforce.com (CRM) | 22-Aug-20 | Option Exercise | 514 | -- | -- | < 1% 100.88K to 101.39K | |
| 18-Jun-20 8:13 PM View: | Salesforce.com (CRM) | 18-Jun-20 | Market Sale (Planned) | 25,000 | $186.57 | $4,664,320.00 | (20%) 125.88K to 100.88K | (22%) |
| 26-May-20 8:55 PM View: | Salesforce.com (CRM) | 22-May-20 | Option Exercise | 514 | -- | -- | < 1% 125.36K to 125.88K | |
| 25-Feb-20 8:17 PM View: | Salesforce.com (CRM) | 22-Feb-20 | Option Exercise | 514 | -- | -- | < 1% 124.85K to 125.36K | |
| 20-Dec-19 4:11 PM View: | Pain Therapeutics Inc. (SAVA) | 20-Dec-19 | Market Purchase | 423,788 | $2.20 | $932,334.00 | 177% 238.84K to 662.62K | 241% |
| 19-Dec-19 6:04 PM View: | Pain Therapeutics Inc. (SAVA) | 19-Dec-19 | Market Purchase | 76,212 | $1.86 | $141,754.00 | 47% 162.62K to 238.84K | 303% |
| 22-Nov-19 7:34 PM View: | Salesforce.com (CRM) | 22-Nov-19 | Grant | 832 | -- | -- | < 1% 124.02K to 124.85K | |
| 03-Sep-19 5:02 PM View: | Salesforce.com (CRM) | 29-Aug-19 | Market Sale | 25,000 | $155.67 | $3,891,730.00 | (17%) 149.02K to 124.02K | (46%) |
| 22-Aug-19 8:32 PM View: | Salesforce.com (CRM) | 22-Aug-19 | Grant | 808 | -- | -- | < 1% 148.21K to 149.02K | |
| 22-May-19 8:18 PM View: | Salesforce.com (CRM) | 22-May-19 | Grant | 782 | -- | -- | < 1% 147.43K to 148.21K | |
| 22-Feb-19 8:26 PM View: | Salesforce.com (CRM) | 22-Feb-19 | Grant | 889 | -- | -- | < 1% 146.54K to 147.43K | |
| 26-Nov-18 6:33 PM View: | Salesforce.com (CRM) | 22-Nov-18 | Grant | 838 | -- | -- | < 1% 145.7K to 146.54K | |
| 27-Sep-18 4:41 PM View: | Pain Therapeutics Inc. (SAVA) | 27-Sep-18 | Market Purchase | 37,817 | $1.05 | $39,707.80 | 30% 124.81K to 162.62K | 608% |
| 26-Sep-18 5:52 PM View: | Pain Therapeutics Inc. (SAVA) | 26-Sep-18 | Market Purchase | 30,992 | $1.05 | $32,541.60 | 33% 93.81K to 124.81K | 608% |
| 26-Sep-18 5:52 PM View: | Pain Therapeutics Inc. (SAVA) | 25-Sep-18 | Market Purchase | 21,420 | $1.00 | $21,420.00 | 30% 72.39K to 93.81K | 643% |
| 26-Sep-18 5:52 PM View: | Pain Therapeutics Inc. (SAVA) | 24-Sep-18 | Market Purchase | 9,771 | $0.96 | $9,380.16 | 16% 62.62K to 72.39K | 679% |
| 17-Sep-18 9:20 PM View: | Salesforce.com (CRM) | 13-Sep-18 | Market Sale | 30,000 | $157.96 | $4,738,850.00 | (17%) 175.7K to 145.7K | (44%) |
| 23-Aug-18 8:52 PM View: | Salesforce.com (CRM) | 22-Aug-18 | Grant | 894 | -- | -- | < 1% 174.81K to 175.7K | |
| 19-Jun-18 7:05 PM View: | Rpx Corp (RPXC) | 19-Jun-18 | Disposition (change in control) | 244,610 | -- | -- | (100%) 244.61K to 0 | |
| 13-Jun-18 7:20 PM View: | Salesforce.com (CRM) | 11-Jun-18 | Market Sale | 30,000 | $134.05 | $4,021,620.00 | (15%) 204.81K to 174.81K | (70%) |
| 22-May-18 8:05 PM View: | Salesforce.com (CRM) | 22-May-18 | Grant | 1,033 | -- | -- | < 1% 203.77K to 204.81K | |
| 22-Feb-18 7:27 PM View: | Salesforce.com (CRM) | 22-Feb-18 | Grant | 1,170 | -- | -- | < 1% 202.6K to 203.77K | |
| 22-Nov-17 4:23 PM View: | Salesforce.com (CRM) | 22-Nov-17 | Grant | 1,298 | -- | -- | < 1% 201.31K to 202.6K | |
| 22-Aug-17 8:53 PM View: | Salesforce.com (CRM) | 22-Aug-17 | Grant | 1,408 | -- | -- | < 1% 199.9K to 201.31K | |
| 15-Jun-17 7:06 PM View: | Rpx Corp (RPXC) | 13-Jun-17 | Grant | 18,150 | -- | -- | 8% 226.46K to 244.61K | |
| 23-May-17 8:29 PM View: | Salesforce.com (CRM) | 22-May-17 | Grant | 1,500 | -- | -- | < 1% 198.4K to 199.9K | |
| 22-Feb-17 9:05 PM View: | Salesforce.com (CRM) | 22-Feb-17 | Grant | 1,718 | -- | -- | < 1% 196.68K to 198.4K | |
| 22-Nov-16 6:28 PM View: | Salesforce.com (CRM) | 22-Nov-16 | Grant | 1,710 | -- | -- | < 1% 194.97K to 196.68K | |
| 23-Aug-16 8:45 PM View: | Salesforce.com (CRM) | 22-Aug-16 | Grant | 1,540 | -- | -- | < 1% 193.43K to 194.97K | |
| 11-Jul-16 7:38 PM View: | Rpx Corp (RPXC) | 08-Jul-16 | Grant | 14,675 | -- | -- | 7% 211.78K to 226.46K | |
| 24-May-16 6:56 PM View: | Salesforce.com (CRM) | 22-May-16 | Grant | 1,695 | -- | -- | < 1% 191.73K to 193.43K | |
| 24-Feb-16 6:35 PM View: | Salesforce.com (CRM) | 22-Feb-16 | Grant | 1,653 | -- | -- | < 1% 190.08K to 191.73K | |
| 23-Nov-15 6:55 PM View: | Salesforce.com (CRM) | 22-Nov-15 | Grant | 1,703 | -- | -- | < 1% 188.38K to 190.08K | |
| 24-Aug-15 6:31 PM View: | Salesforce.com (CRM) | 22-Aug-15 | Grant | 1,725 | -- | -- | < 1% 186.65K to 188.38K | |
| 10-Jun-15 8:06 PM View: | Rpx Corp (RPXC) | 09-Jun-15 | Grant | 11,337 | -- | -- | 6% 200.45K to 211.78K | |
| 22-May-15 8:08 PM View: | Salesforce.com (CRM) | 22-May-15 | Grant | 1,862 | -- | -- | 1% 184.79K to 186.65K | |
| 23-Feb-15 9:05 PM View: | Salesforce.com (CRM) | 22-Feb-15 | Grant | 2,159 | -- | -- | 1% 182.63K to 184.79K | |
| 25-Nov-14 4:48 PM View: | Salesforce.com (CRM) | 25-Nov-14 | Grant | 2,161 | -- | -- | 1% 180.47K to 182.63K | |
| 26-Aug-14 7:34 PM View: | Salesforce.com (CRM) | 26-Aug-14 | Grant | 2,275 | -- | -- | 1% 178.2K to 180.47K | |
| 01-Aug-14 7:52 PM View: | Dolby Laboratories Inc. (DLB) | 31-Jul-14 | Option Exercise | 25,059 | $24.69 | $618,738.00 | 580% 4.32K to 29.38K | |
| 01-Aug-14 7:52 PM View: | Dolby Laboratories Inc. (DLB) | 31-Jul-14 | Market Option Sale | 21,346 | $44.71 | $954,333.00 | (73%) 29.38K to 8.04K | (101%) |
| 01-Aug-14 7:52 PM View: | Dolby Laboratories Inc. (DLB) | 31-Jul-14 | Market Sale | 3,713 | $44.71 | $166,000.00 | (46%) 8.04K to 4.32K | (101%) |
| 01-Aug-14 7:52 PM View: | Dolby Laboratories Inc. (DLB) | 30-Jul-14 | Market Option Sale | 3,713 | $45.01 | $167,119.00 | (9%) 41.26K to 37.55K | (99%) |
| 01-Aug-14 7:52 PM View: | Dolby Laboratories Inc. (DLB) | 30-Jul-14 | Market Sale | 33,222 | $45.01 | $1,495,300.00 | (88%) 37.55K to 4.32K | (99%) |
| 19-Jun-14 3:34 PM View: | Rpx Corp (RPXC) | 17-Jun-14 | Grant | 9,559 | -- | -- | 5% 190.89K to 200.45K |